Overview
- The report draws on more than 4 million diagnostic results and 19 million medicine orders gathered across 29 states and union territories from January 2021 to September 2025.
- Nearly one in three HbA1c tests fell in the diabetic range and one in four indicated prediabetes, so over half of those tested had irregular glucose levels.
- Elevated readings were detected even under age 30, and prevalence peaked after 60 when about eight in ten tested in the diabetic or prediabetic ranges.
- Among those with high sugar, comorbidities were common: roughly one in four had thyroid abnormalities, one in three had liver dysfunction, nearly half had kidney impairment, and about 90% had abnormal lipid profiles.
- Rates were higher in men than women (about 52% vs 45%) and in southern/coastal states such as Puducherry, Odisha, Tamil Nadu and Goa compared with Himachal Pradesh, while diabetes drugs rose to 34% of platform orders in 2024 and 22% of retested users normalized within six months.